A Regulatory T-Cell Gene Signature Is a Specific and Sensitive Biomarker to Identify Children With New-Onset Type 1 Diabetes

Type 1 diabetes (T1D) is caused by immune-mediated destruction of insulin-producing β-cells. Insufficient control of autoreactive T cells by regulatory T cells (Tregs) is believed to contribute to disease pathogenesis, but changes in Treg function are difficult to quantify because of the lack of Treg-exclusive markers in humans and the complexity of functional experiments. We established a new way to track Tregs by using a gene signature that discriminates between Tregs and conventional T cells regardless of their activation states. The resulting 31-gene panel was validated with the NanoString nCounter platform and then measured in sorted CD4+CD25hiCD127lo Tregs from children with T1D and age-matched control subjects. By using biomarker discovery analysis, we found that expression of a combination of six genes, including TNFRSF1B (CD120b) and FOXP3, was significantly different between Tregs from subjects with new-onset T1D and control subjects, resulting in a sensitive (mean ± SD 0.86 ± 0.14) and specific (0.78 ± 0.18) biomarker algorithm. Thus, although the proportion of Tregs in peripheral blood is similar between children with T1D and control subjects, significant changes in gene expression can be detected early in disease process. These findings provide new insight into the mechanisms underlying the failure to control autoimmunity in T1D and might lead to a biomarker test to monitor Tregs throughout disease progression.

[1]  B. Stranger,et al.  Interindividual variation in human T regulatory cells , 2014, Proceedings of the National Academy of Sciences.

[2]  Elizabeth Whalen,et al.  Multiple Autoimmune-Associated Variants Confer Decreased IL-2R Signaling in CD4+CD25hi T Cells of Type 1 Diabetic and Multiple Sclerosis Patients , 2013, PloS one.

[3]  M. Netea,et al.  TNFR2 Is Critical for the Stabilization of the CD4+Foxp3+ Regulatory T Cell Phenotype in the Inflammatory Environment , 2013, The Journal of Immunology.

[4]  Raymond T. Ng,et al.  A computational pipeline for the development of multi-marker bio-signature panels and ensemble classifiers , 2012, BMC Bioinformatics.

[5]  Linda S. Wicker,et al.  Type 1 Diabetes-Associated IL2RA Variation Lowers IL-2 Signaling and Contributes to Diminished CD4+CD25+ Regulatory T Cell Function , 2012, The Journal of Immunology.

[6]  Mark A. Atkinson,et al.  Central Role for Interleukin-2 in Type 1 Diabetes , 2011, Diabetes.

[7]  J. Buckner,et al.  CD4+FOXP3+ T Regulatory Cells in Human Autoimmunity: More Than a Numbers Game , 2011, The Journal of Immunology.

[8]  Xin Chen,et al.  The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4+ FoxP3+ regulatory T cells , 2011, Immunology.

[9]  F. Nichols,et al.  Natural but Not Inducible Regulatory T Cells Require TNF-α Signaling for In Vivo Function , 2011, The Journal of Immunology.

[10]  Jonathan H. Esensten,et al.  Plasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes , 2011, The Journal of Immunology.

[11]  Jeff E. Mold,et al.  Fetal and Adult Hematopoietic Stem Cells Give Rise to Distinct T Cell Lineages in Humans , 2010, Science.

[12]  Q. Ouyang,et al.  Cutting Edge: Increased IL-17–Secreting T Cells in Children with New-Onset Type 1 Diabetes , 2010, The Journal of Immunology.

[13]  K. Cerosaletti,et al.  An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4+ T cells , 2010, Genes and Immunity.

[14]  Jano I van Hemert,et al.  Correcting for intra-experiment variation in Illumina BeadChip data is necessary to generate robust gene-expression profiles , 2010, BMC Genomics.

[15]  M. Probst-Kepper,et al.  FOXP3 and GARP (LRRC32): the master and its minion , 2010, Biology Direct.

[16]  C Polychronakos,et al.  The type I diabetes association of the IL2RA locus , 2009, Genes and Immunity.

[17]  M. Battaglia,et al.  The Tregs' world according to GARP , 2009, European journal of immunology.

[18]  P. Coulie,et al.  Membrane protein GARP is a receptor for latent TGF‐β on the surface of activated human Treg , 2009, European journal of immunology.

[19]  K. Cerosaletti,et al.  Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4+CD25+ Regulatory T-Cells of Type 1 Diabetic Subjects , 2009, Diabetes.

[20]  Matthew Hardy,et al.  Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource , 2009, Nature Genetics.

[21]  Purushottam W. Laud,et al.  Apoptosis of CD4+CD25high T Cells in Type 1 Diabetes May Be Partially Mediated by IL-2 Deprivation , 2009, PloS one.

[22]  T. Gerds,et al.  Diagnosis of ulcerative colitis before onset of inflammation by multivariate modeling of genome‐wide gene expression data , 2009, Inflammatory bowel diseases.

[23]  T. Nomura,et al.  Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. , 2009, Immunity.

[24]  E. Sgouroudis,et al.  Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lessons from mouse models and implications for human disease , 2009, Diabetes/metabolism research and reviews.

[25]  C. Benoist,et al.  The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors , 2008, Proceedings of the National Academy of Sciences.

[26]  M. Peakman,et al.  Increased resistance to CD4+CD25hi regulatory T cell‐mediated suppression in patients with type 1 diabetes , 2008, Clinical and experimental immunology.

[27]  W. Friedrich,et al.  Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. , 2008, The Journal of allergy and clinical immunology.

[28]  H. Tojo,et al.  Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells. , 2008, International immunology.

[29]  A. Rudensky,et al.  Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3 , 2007, Nature Immunology.

[30]  M. Ramoni,et al.  Multiparameter Immune Profiling of Operational Tolerance in Liver Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  M. Battaglia,et al.  Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1 , 2006, The Journal of Immunology.

[32]  M. Probst-Kepper,et al.  Signatures of human regulatory T cells: an encounter with old friends and new players , 2006, Genome Biology.

[33]  J. Mesirov,et al.  GenePattern 2.0 , 2006, Nature Genetics.

[34]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[35]  M. Peakman,et al.  Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. , 2005, Diabetes.